Literature DB >> 36018456

Putative anoikis resistant subpopulations are enriched in lymph node metastases and indicate adverse prognosis in colorectal carcinoma.

Taneli T Mattila1,2, Madhura Patankar3, Juha P Väyrynen1,2, Kai Klintrup4,5, Jyrki Mäkelä4,5, Anne Tuomisto1,2, Pentti Nieminen6, Markus J Mäkinen1,2, Tuomo J Karttunen7,8.   

Abstract

Anoikis refers to apoptosis induced by the loss of contact with the extracellular matrix. Anoikis resistance is essential for metastasis. We have recently shown that it is possible to quantitatively evaluate putative anoikis resistant (AR) subpopulations in colorectal carcinoma (CRC). Abundance of these multi-cell structures is an independent marker of adverse prognosis. Here, we have quantified putative AR subpopulations in lymph node (LN) metastases of CRC and evaluated their prognostic value and relationship with the characteristics of primary tumors. A case series included 137 unselected CRC patients, 54 with LN metastases. Areal densities (structures/mm2) of putative AR structures in primary tumors had been analyzed previously and now were determined from all nodal metastases (n = 183). Areal density of putative AR structures was higher in LN metastases than in primary tumors. Variation of the areal density within different LN metastases of a single patient was lower than between metastases of different patients. Abundance of putative AR structures in LN metastases was associated with shorter cancer specific survival (p = 0.013), and this association was independent of T and N stages. Abundance of putative AR structures in primary tumors and LN metastases had a cumulative adverse effect on prognosis. Enrichment of putative AR subpopulations in LN metastases suggest that in metastasis formation, there is a selection favoring cells capable of forming these structures. Higher intra-case constancy relative to inter-case variation suggests that such selection is stable in metastasis development. Our findings indirectly support the biological validity of our concept of putative AR structures.
© 2022. The Author(s).

Entities:  

Keywords:  Anoikis; Colorectal carcinoma; Cribriform; Micropapillary; Solid

Year:  2022        PMID: 36018456     DOI: 10.1007/s10585-022-10184-5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   4.510


  35 in total

Review 1.  Anoikis.

Authors:  A P Gilmore
Journal:  Cell Death Differ       Date:  2005-11       Impact factor: 15.828

Review 2.  What We Know About Stage II and III Colon Cancer: It's Still Not Enough.

Authors:  Alberto Puccini; Martin D Berger; Wu Zhang; Heinz-Josef Lenz
Journal:  Target Oncol       Date:  2017-06       Impact factor: 4.493

Review 3.  Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis.

Authors:  N Veronese; A Nottegar; A Pea; M Solmi; B Stubbs; P Capelli; G Sergi; E Manzato; M Fassan; L D Wood; A Scarpa; C Luchini
Journal:  Ann Oncol       Date:  2015-10-19       Impact factor: 32.976

4.  Global Burden of 5 Major Types of Gastrointestinal Cancer.

Authors:  Melina Arnold; Christian C Abnet; Rachel E Neale; Jerome Vignat; Edward L Giovannucci; Katherine A McGlynn; Freddie Bray
Journal:  Gastroenterology       Date:  2020-04-02       Impact factor: 22.682

5.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Authors:  Jessica B O'Connell; Melinda A Maggard; Clifford Y Ko
Journal:  J Natl Cancer Inst       Date:  2004-10-06       Impact factor: 13.506

6.  Disruption of epithelial cell-matrix interactions induces apoptosis.

Authors:  S M Frisch; H Francis
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

7.  Cancer cell resistance to anoikis: MUC1 glycosylation comes to play.

Authors:  Lu-Gang Yu
Journal:  Cell Death Dis       Date:  2017-07-27       Impact factor: 8.469

8.  HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.

Authors:  Feifei Chen; Lei Zhang; Jianqiang Wu; Fuchun Huo; Xin Ren; Junnian Zheng; Dongsheng Pei
Journal:  Cell Death Dis       Date:  2018-12-05       Impact factor: 8.469

Review 9.  Integrin α6β4 in Colorectal Cancer: Expression, Regulation, Functional Alterations and Use as a Biomarker.

Authors:  Jean-François Beaulieu
Journal:  Cancers (Basel)       Date:  2019-12-21       Impact factor: 6.639

10.  Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study.

Authors:  V Väyrynen; E-V Wirta; T Seppälä; E Sihvo; J-P Mecklin; K Vasala; I Kellokumpu
Journal:  BJS Open       Date:  2020-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.